Tarling Elizabeth J, Edwards Peter A
From the Departments of Biological Chemistry (P.A.E.) and Medicine (E.J.T.), David Geffen School of Medicine at the University of California, Los Angeles.
Arterioscler Thromb Vasc Biol. 2016 Jul;36(7):1323-7. doi: 10.1161/ATVBAHA.116.307414. Epub 2016 May 26.
In a recent article in Arteriosclerosis, Thrombosis, and Vascular Biology, it was reported that ATP-binding cassette transporter G1 (ABCG1) containing leucine at position 550 (ABCG1-L550) was localized to the plasma membrane, whereas ABCG1-P550 (proline at position 550) was intracellular. Because the published data on the subcellular localization of ABCG1 are controversial, we performed additional experiments to determine the importance of leucine or proline at amino acid 550.
We transfected multiple cell lines (CHO-K1, Cos-7, and HEK293 [human embryonic kidney]) with untagged or FLAG-tagged ABCG1 containing either leucine or proline at position 550. Immunofluorescence studies demonstrated that in all cases, ABCG1 localized to intracellular endosomal vesicles. We also show that both ABCG1-L550 and ABCG1-P550 are equally active in both promoting the efflux of cellular cholesterol to exogenous high-density lipoprotein and in inducing the activity of sterol regulatory element-binding protein-2, presumably as a result of redistributing intracellular sterols away from the endoplasmic reticulum. Importantly, we treated nontransfected primary peritoneal macrophages with a liver X receptor agonist and demonstrate, using immunofluorescence, that although endogenous ABCG1 localizes to intracellular endosomes, none was detectable at the cell surface/plasma membrane.
ABCG1, irrespective of either a leucine or proline at position 550, is an intracellular protein that localizes to vesicles of the endosomal pathway where it functions to mobilize sterols away from the endoplasmic reticulum and out of the cell.
在最近发表于《动脉硬化、血栓形成和血管生物学》的一篇文章中,有报道称,第550位含亮氨酸的ATP结合盒转运蛋白G1(ABCG1-L550)定位于质膜,而ABCG1-P550(第550位为脯氨酸)定位于细胞内。由于已发表的关于ABCG1亚细胞定位的数据存在争议,我们进行了额外的实验,以确定第550位氨基酸处亮氨酸或脯氨酸的重要性。
我们用第550位含亮氨酸或脯氨酸的未标记或FLAG标记的ABCG1转染多种细胞系(CHO-K1、Cos-7和HEK293[人胚肾细胞])。免疫荧光研究表明,在所有情况下,ABCG1都定位于细胞内的内体小泡。我们还表明,ABCG1-L550和ABCG1-P550在促进细胞胆固醇向外源性高密度脂蛋白的流出以及诱导固醇调节元件结合蛋白-2的活性方面同样活跃,这可能是由于将细胞内固醇从内质网重新分布的结果。重要的是,我们用肝X受体激动剂处理未转染的原代腹腔巨噬细胞,并通过免疫荧光证明,尽管内源性ABCG1定位于细胞内的内体,但在细胞表面/质膜上未检测到。
无论第550位是亮氨酸还是脯氨酸,ABCG1都是一种细胞内蛋白,定位于内体途径的小泡,在其中发挥作用,将固醇从内质网转运出细胞。